Daiichi Sankyo Nordics ApS: Financial statements 2019
CVR: 39371049
Source: annual report 2019, Danish Business Authority
28/02/2018 – 31/03/2019
Daiichi Sankyo Nordics ApS (CVR 39371049) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,876,751 and a net result of DKK 253,181. Equity in the 2019 report amounted to DKK 1,303,181. The solvency ratio was 33.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,876,751
- Profit/Loss
- DKK 253,181
- Equity
- DKK 1,303,181
- Total Assets
- DKK 3,915,468
- Employees
- 2
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 11, 2019, Stefan Gerd Koch has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Patrik Josef Mag. Grandits has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Stefan Gerd Koch has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Tim Ellmers has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Stefan Gerd Koch has left the board of directors of Daiichi Sankyo Nordics ApS.
On September 11, 2019, the company changed its name from Daiichi Sankyo Oncology Nordics ApS to Daiichi Sankyo Nordics ApS.
About Daiichi Sankyo Nordics ApS
Daiichi Sankyo Nordics ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Daiichi Sankyo Oncology Nordics ApS. The management consists of Christophe Tiberghien. The board consists of Christophe Tiberghien, Jacob Wessel-Tolvig and Karin Margaretha Heisterberg. The company is owned by Daiichi Sankyo Oncology Europe GmbH. The company has 32 employees (2026). In 2026, the company reported a gross profit of DKK 83,558,930 and a net result of DKK 17,269,490 compared with DKK 9,020,707 the year before. Equity in the 2026 report amounted to DKK 40,346,412.